Dr. Borgerding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1176 5th Avenue
Floor 9
New York, NY 10029
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Obstetrics and Gynecology, 2022 - 2026
- Icahn School of Medicine at Mount SinaiClass of 2022
- Icahn School of Medicine at Mount SinaiPhD, Immunology, 2014 - 2020
- University College LondonMSc, History and Philosophy of Science, 2013 - 2014
- Washington University in St. LouisBA, Biochemistry, Philosophy of Science, 2009 - 2013
Publications & Presentations
PubMed
- 31 citationsModeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.James Carter, Dipankar Bhattacharya, Joshua N. Borgerding, M. Isabel Fiel, Jeremiah J. Faith
Plos One. 2021-01-04 - 122 citationsFecal IgA Levels Are Determined by Strain-Level Differences in Bacteroides ovatus and Are Modifiable by Gut Microbiota Manipulation.Chao Yang, Ilaria Mogno, Eduardo J. Contijoch, Joshua N. Borgerding, Varun Aggarwala
Cell Host & Microbe. 2020-03-11 - 12 citationsIBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel DiseasePauline Danion, Anthony Buisson, Xavier Roblin, Nicolas Mathieu, Anne-Laure Charlois
Inflammatory Bowel Diseases. 2018-04-23
Grant Support
- Identifying Immune Mechanisms for Microbiota-Inhibition of Anti-PD-L1 Tumor ResponseNational Cancer Institute2018–2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: